Menopause News

Menopause should not be treated as a problem to be solved. Rather, it should be normalized, according to an analysis published in the BMJ.

Women exposed to higher concentrations of a class of endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances are at increased risk for incident hypertension, researchers reported.

A joint statement from three medical organizations advised health care professionals to recognize that women experiencing menopause need individualized treatment options.

Healthy lifestyle habits before and during menopause may delay or lessen severe metabolic conditions in women caused by potential increases in adiposity, according to findings published in Aging Cell.

Women with more visceral adipose tissue during menopause transition have worse HDL metrics, and insulin resistance is a mediating factor in some of the associations, according to study data.

Menopausal women tend to have worse cardiovascular risk profiles than premenopausal women, but 5-year increases in CV risk factors are not dependent on reproductive stage, according to data from the CoLaus study.

The intensity of temporomandibular disorder-induced pain was linked to menopausal symptom intensity, with the strongest correlation observed in the late menopausal transition, according to a cross-sectional study in Menopause.

Hormonal changes during the menopause transition are associated with a “proatherogenic metabolomic fingerprint” that modulates lipoprotein and lipid metabolism, including significant changes in HDL and LDL, researchers reported.

SAN DIEGO — Compared with placebo, fezolinetant was efficacious in the treatment of menopause-related vasomotor symptoms with no safety concerns, according to phase 3 data presented at the ACOG Annual Clinical & Scientific Meeting.

Postmenopausal women assigned denosumab have increases in mineral to matrix ratio at the cortical and cancellous bone at 2 to 3 years, but changes were not observed beyond 5 years, according to study findings.